Likewise, the HF-ACTION investigators only assessed the additional mode-specific death information gained from adding biomarkers, i.e. NT-proBNP, galectin-3 and soluble ST2, to a clinical model developed previously for all-cause death [6, 27]. The gene discussed is LGALS3; the disease is hydrops fetalis.